| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 152, Issue 4 1523-1531, Copyright © 1994 by American Association of Immunologists
ARTICLES |
M Cayabyab, JH Phillips and LL Lanier
DNAX Research Institute of Molecular and Cellular Biology, Department of Immunology, Palo Alto, CA 94304.
CD40 is a membrane differentiation antigen constitutively expressed on B cells that induces B cell growth and Ig synthesis after ligation with anti-CD40 mAb or with the recently identified CD40 ligand (CD40L). CD40L is rapidly induced on T cells after activation with anti-CD3 mAb or mitogens. While CD40-CD40L interactions are clearly beneficial to B cells, we speculated that a reciprocal costimulation of T cells might also occur. We have used genetic transfection to demonstrate that interactions between human small, resting T cells and CD40+ murine transfectants substantially augmented anti-CD3 induced T cell proliferation and resulted in the generation of CTL. T cell proliferation costimulated by CD40 was IL-2 dependent. The ability of CD40+ transfectants to costimulate T cell proliferation was specific in that VCAM-1+, CD54+, CD72+, CD56+, CD31+, and fas+ transfectants in the same host cells were inactive. CD4+ T cells preferentially responded to CD40 costimulation, whereas CD8+ T cells were substantially less reactive. By contrast, costimulation with B7 transfectants induced equivalent proliferation in the CD4+ and CD8+ T cell subsets. In addition, adult naive and memory T cells, as well as cord blood T cells, were responsive to CD40. These findings suggest that the CD40- CD40L costimulation pathway may allow for selective expansion of CD4+ T cells after interaction with CD40-bearing APC. The relatively restricted expression of CD40 on APC, as well as on medullary and cortical thymic epithelium, indicates a possible role for this interaction in T cell differentiation and activation.
This article has been cited by other articles:
|
|
 |
|
  M. Sun and P. J. Fink A New Class of Reverse Signaling Costimulators Belongs to the TNF Family J. Immunol., October 1, 2007; 179(7): 4307 - 4312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Hewitson, P. A. Hamblin, and A. P. Mountford In the Absence of CD154, Administration of Interleukin-12 Restores Th1 Responses but Not Protective Immunity to Schistosoma mansoni Infect. Immun., July 1, 2007; 75(7): 3539 - 3547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Hewitson, G. R. Jenkins, P. A. Hamblin, and A. P. Mountford CD40/CD154 Interactions Are Required for the Optimal Maturation of Skin-Derived APCs and the Induction of Helminth-Specific IFN-{gamma} but Not IL-4. J. Immunol., September 1, 2006; 177(5): 3209 - 3217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sun, K. T. Ames, I. Suzuki, and P. J. Fink The Cytoplasmic Domain of Fas Ligand Costimulates TCR Signals J. Immunol., August 1, 2006; 177(3): 1481 - 1491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. F. Rousseau, E. Biagi, A. Dutour, E. S. Yvon, M. P. Brown, T. Lin, Z. Mei, B. Grilley, E. Popek, H. E. Heslop, et al. Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation Blood, February 15, 2006; 107(4): 1332 - 1341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Shi, J. Mao, G. Yu, J. Zhang, and J. Wu Tumor Vaccine Based on Cell Surface Expression of DcR3/TR6 J. Immunol., April 15, 2005; 174(8): 4727 - 4735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-R. Yang, S.-L. Hsieh, F.-M. Ho, and W.-W. Lin Decoy Receptor 3 Increases Monocyte Adhesion to Endothelial Cells via NF-{kappa}B-Dependent Up-Regulation of Intercellular Adhesion Molecule-1, VCAM-1, and IL-8 Expression J. Immunol., February 1, 2005; 174(3): 1647 - 1656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Arens, M. A. Nolte, K. Tesselaar, B. Heemskerk, K. A. Reedquist, R. A. W. van Lier, and M. H. J. van Oers Signaling through CD70 Regulates B Cell Activation and IgG Production J. Immunol., September 15, 2004; 173(6): 3901 - 3908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-J. Lee, L. Myers, G. Muralimohan, J. Dai, Y. Qiao, Z. Li, R. S. Mittler, and A. T. Vella 4-1BB and OX40 Dual Costimulation Synergistically Stimulate Primary Specific CD8 T Cells for Robust Effector Function J. Immunol., September 1, 2004; 173(5): 3002 - 3012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tahara-Hanaoka, K. Shibuya, Y. Onoda, H. Zhang, S. Yamazaki, A. Miyamoto, S.-i. Honda, L. L. Lanier, and A. Shibuya Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112) Int. Immunol., April 1, 2004; 16(4): 533 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. V. Proussakova, N. A. Rabaya, A. B. Moshnikova, E. S. Telegina, A. Turanov, M. G. Nanazashvili, and I. P. Beletsky Oligomerization of Soluble Fas Antigen Induces Its Cytotoxicity J. Biol. Chem., September 19, 2003; 278(38): 36236 - 36241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Eshima, Y. Choi, and R. A. Flavell CD154-CD40-independent up-regulation of B7-2 on splenic antigen-presenting cells and efficient T cell priming by staphylococcal enterotoxin A Int. Immunol., July 1, 2003; 15(7): 817 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Rudner, J. T. Lin, I.-K. Park, J. M. M. Cates, D. A. Dyer, D. M. Franz, M. A. French, E. M. Duncan, H. D. White, and J. D. Gorham Necroinflammatory Liver Disease in BALB/c Background, TGF-{beta}1-Deficient Mice Requires CD4+ T Cells J. Immunol., May 1, 2003; 170(9): 4785 - 4792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wan, J. Zhang, H. Luo, G. Shi, E. Kapnik, S. Kim, P. Kanakaraj, and J. Wu A TNF Family Member LIGHT Transduces Costimulatory Signals into Human T Cells J. Immunol., December 15, 2002; 169(12): 6813 - 6821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Shi, H. Luo, X. Wan, T. W. Salcedo, J. Zhang, and J. Wu Mouse T cells receive costimulatory signals from LIGHT, a TNF family member Blood, October 16, 2002; 100(9): 3279 - 3286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-L. Hsu, Y.-C. Chang, S.-J. Chen, Y.-J. Liu, A. W. Chiu, C.-C. Chio, L. Chen, and S.-L. Hsieh Modulation of Dendritic Cell Differentiation and Maturation by Decoy Receptor 3 J. Immunol., May 15, 2002; 168(10): 4846 - 4853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-H. Chou, H.-F. Tsai, L.-L. Lin, S.-L. Hsieh, P.-I Hsu, and P.-N. Hsu Enhanced Proliferation and Increased IFN-{gamma} Production in T Cells by Signal Transduced Through TNF-Related Apoptosis-Inducing Ligand J. Immunol., August 1, 2001; 167(3): 1347 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lindgren, K. Axcrona, and T. Leanderson Regulation of Transcriptional Activity of the Murine CD40 Ligand Promoter in Response to Signals Through TCR and the Costimulatory Molecules CD28 and CD2 J. Immunol., April 1, 2001; 166(7): 4578 - 4585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Quesenberry, S. Zhong, H. Wang, and M. Stewart Allogeneic chimerism with low-dose irradiation, antigen presensitization, and costimulator blockade in H-2 mismatched mice Blood, January 15, 2001; 97(2): 557 - 564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Storz, K. Zepter, J. Kamarashev, R. Dummer, G. Burg, and A. C. Häffner Coexpression of CD40 and CD40 Ligand in Cutaneous T-Cell Lymphoma (Mycosis Fungoides) Cancer Res., January 1, 2001; 61(2): 452 - 454. [Abstract] [Full Text]
|
|
|
|
|
|
N.-J. Chen, M.-W. Huang, and S.-L. Hsieh Enhanced Secretion of IFN-{{gamma}} by Activated Th1 Cells Occurs Via Reverse Signaling Through TNF-Related Activation-Induced Cytokine J. Immunol., January 1, 2001; 166(1): 270 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Subauste and M. Wessendarp Human Dendritic Cells Discriminate Between Viable and Killed Toxoplasma gondii Tachyzoites: Dendritic Cell Activation After Infection with Viable Parasites Results in CD28 and CD40 Ligand Signaling That Controls IL-12-Dependent and -Independent T Cell Production of IFN-{gamma} J. Immunol., August 1, 2000; 165(3): 1498 - 1505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cerutti, A. Schaffer, R. G. Goodwin, S. Shah, H. Zan, S. Ely, and P. Casali Engagement of CD153 (CD30 Ligand) by CD30+ T Cells Inhibits Class Switch DNA Recombination and Antibody Production in Human IgD+ IgM+ B Cells J. Immunol., July 15, 2000; 165(2): 786 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Pirozzi, V. Lombari, D. Zanzi, F. Ionna, M. L. Lombardi, S. Errico, G. Ruggiero, and C. Manzo CD40 expressed on human melanoma cells mediates T cell co-stimulation and tumor cell growth Int. Immunol., June 1, 2000; 12(6): 787 - 795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Kaplan, D. Ray, R.-R. Mo, R. L. Yung, and B. C. Richardson TRAIL (Apo2 Ligand) and TWEAK (Apo3 Ligand) Mediate CD4+ T Cell Killing of Antigen-Presenting Macrophages J. Immunol., March 15, 2000; 164(6): 2897 - 2904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. van Broekhoven, C. R. Parish, G. Vassiliou, and J. G. Altin Engrafting Costimulator Molecules onto Tumor Cell Surfaces with Chelator Lipids: A Potentially Convenient Approach in Cancer Vaccine Development J. Immunol., March 1, 2000; 164(5): 2433 - 2443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Blair, J. L. Riley, D. M. Harlan, R. Abe, D. K. Tadaki, S. C. Hoffmann, L. White, T. Francomano, S. J. Perfetto, A. D. Kirk, et al. CD40 Ligand (CD154) Triggers a Short-Term CD4+ T Cell Activation Response That Results in Secretion of Immunomodulatory Cytokines and Apoptosis J. Exp. Med., February 21, 2000; 191(4): 651 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hannier and F. Triebel The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes Int. Immunol., November 1, 1999; 11(11): 1745 - 1752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Grammer, R. D. McFarland, J. Heaney, B. F. Darnell, and P. E. Lipsky Expression, Regulation, and Function of B Cell-Expressed CD154 in Germinal Centers J. Immunol., October 15, 1999; 163(8): 4150 - 4159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E Donovan and P. W Finn Immune mechanisms of childhood asthma Thorax, October 1, 1999; 54(10): 938 - 946. [Full Text]
|
|
|
|
|
|
D. M. Shepherd and N. I. Kerkvliet Disruption of CD154:CD40 Blocks Generation of Allograft Immunity Without Affecting APC Activation J. Immunol., September 1, 1999; 163(5): 2470 - 2477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Buhmann, A. Nolte, D. Westhaus, B. Emmerich, and M. Hallek CD40-Activated B-Cell Chronic Lymphocytic Leukemia Cells for Tumor Immunotherapy: Stimulation of Allogeneic Versus Autologous T Cells Generates Different Types of Effector Cells Blood, March 15, 1999; 93(6): 1992 - 2002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. v. Leoprechting, P. van der Bruggen, H. L. Pahl, A. Aruffo, and J. C. Simon Stimulation of CD40 on Immunogenic Human Malignant Melanomas Augments Their Cytotoxic T Lymphocyte-mediated Lysis and Induces Apoptosis Cancer Res., March 1, 1999; 59(6): 1287 - 1294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lang, T. L. Whiteside, A. Lebeau, R. Zeidler, B. Mack, and B. Wollenberg Impairment of T-Cell Activation in Head and Neck Cancer In Situ and In Vitro: Strategies for an Immune Restoration Arch Otolaryngol Head Neck Surg, January 1, 1999; 125(1): 82 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Gramaglia, A. D. Weinberg, M. Lemon, and M. Croft Ox-40 Ligand: A Potent Costimulatory Molecule for Sustaining Primary CD4 T Cell Responses J. Immunol., December 15, 1998; 161(12): 6510 - 6517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Waldrop, K. A. Davis, V. C. Maino, and L. J. Picker Normal Human CD4+ Memory T Cells Display Broad Heterogeneity in Their Activation Threshold for Cytokine Synthesis J. Immunol., November 15, 1998; 161(10): 5284 - 5295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Sharma, M. Leite de Moraes, F. Zavala, C. Pontoux, and M. Papiernik Induction and Inhibition of CD40-CD40 Ligand Interactions: A New Strategy Underlying Host-Virus Relationships J. Immunol., November 15, 1998; 161(10): 5357 - 5365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Tangye, J. Wu, G. Aversa, J. E. de Vries, L. L. Lanier, and J. H. Phillips Cutting Edge: Negative Regulation of Human T Cell Activation by the Receptor-Type Protein Tyrosine Phosphatase CD148 J. Immunol., October 15, 1998; 161(8): 3803 - 3807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Tangye, J. H. Phillips, L. L. Lanier, J. E. de Vries, and G. Aversa CD148: A Receptor-Type Protein Tyrosine Phosphatase Involved in the Regulation of Human T Cell Activation J. Immunol., October 1, 1998; 161(7): 3249 - 3255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Fuller, B. Wong, S. Fox, Y. Choi, and T. J. Chambers TRANCE Is Necessary and Sufficient for Osteoblast-mediated Activation of Bone Resorption in Osteoclasts J. Exp. Med., September 7, 1998; 188(5): 997 - 1001. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Q. Russell, T. Mooney, P. L. Cohen, B. MacPherson, R. J. Noelle, and R. C. Budd Anti-CD40L Accelerates Renal Disease and Adenopathy in MRL-lpr Mice in Parallel with Decreased Thymocyte Apoptosis J. Immunol., July 15, 1998; 161(2): 729 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Saito, J. Sakurai, J. Ohata, T. Kohsaka, H. Hashimoto, K. Okumura, R. Abe, and M. Azuma Involvement of CD40 Ligand-CD40 and CTLA4-B7 Pathways in Murine Acute Graft-Versus-Host Disease Induced by Allogeneic T Cells Lacking CD28 J. Immunol., May 1, 1998; 160(9): 4225 - 4231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Macaulay, R. H. DeKruyff, and D. T. Umetsu Antigen-Primed T Cells from B Cell-Deficient JHD Mice Fail to Provide B Cell Help J. Immunol., February 15, 1998; 160(4): 1694 - 1700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. W. Wright, C. J. Johnston, A. G. Harmsen, and J. N. Finkelstein Analysis of Cytokine mRNA Profiles in the Lungs of Pneumocystis carinii-infected Mice Am. J. Respir. Cell Mol. Biol., October 1, 1997; 17(4): 491 - 500. [Abstract] [Full Text]
|
|
|
|
|
|
D. Dilloo, M. Brown, M. Roskrow, W. Zhong, M. Holladay, W. Holden, and M. Brenner CD40 Ligand Induces an Antileukemia Immune Response In Vivo Blood, September 1, 1997; 90(5): 1927 - 1933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Carbone, G. Ruggiero, G. Terrazzano, C. Palomba, C. Manzo, S. Fontana, H. Spits, K. Karre, and S. Zappacosta A New Mechanism of NK Cell Cytotoxicity Activation: The CD40-CD40 Ligand Interaction J. Exp. Med., June 16, 1997; 185(12): 2053 - 2060. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. W. Hancock, M. H. Sayegh, X.-G. Zheng, R. Peach, P. S. Linsley, and L. A. Turka Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection PNAS, November 26, 1996; 93(24): 13967 - 13972. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
